Standardized endpoint definitions for transcatheter aortic valve implantation clinical trials: A consensus report from the valve academic research consortium

Journal of the American College of Cardiology

Volumn 57, Issue 3, 2011, Pages 253-269

  Leon, Martin B ^a   Piazza, Nicolo ^a   Nikolsky, Eugenia ^a   Blackstone, Eugene H ^a   Cutlip, Donald E ^a   Kappetein, Arie Pieter ^a   Krucoff, Mitchell W ^a   MacK, Michael ^a   Mehran, Roxana ^a   Miller, Craig ^a   Morel, Marie Angle ^a   Petersen, John ^a   Popma, Jeffrey J ^a   Takkenberg, Johanna J M ^a   Vahanian, Alec ^a   Van Es, Gerrit Anne ^a   Vranckx, Pascal ^a   Webb, John G ^a   Windecker, Stephan ^a   Serruys, Patrick W ^a  

^a NewYork Presbyterian Hospital   (United States)

Author keywords

transcatheter aortic valve implantation

Indexed keywords

ACUTE KIDNEY FAILURE; AORTA STENOSIS; AORTA VALVE REGURGITATION; ARTICLE; BLEEDING; CARDIOVASCULAR PROCEDURES; CLINICAL PRACTICE; CLINICAL RESEARCH; CLINICAL TRIAL (TOPIC); CORONARY ARTERY OBSTRUCTION; DEVICE; HEART ARRHYTHMIA; HEART INFARCTION; HEART MUSCLE CONDUCTION DISTURBANCE; HEART VALVE PROSTHESIS; HUMAN; INVASIVE PROCEDURE; MORTALITY; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROSTHETIC VALVE THROMBOSIS; RISK ASSESSMENT; STROKE; TRANSCATHETER AORTIC VALVE IMPLANTATION;

ANIMALS; AORTIC VALVE; AORTIC VALVE STENOSIS; CLINICAL TRIALS AS TOPIC; ENDPOINT DETERMINATION; HEART CATHETERIZATION; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; NETHERLANDS; POSTOPERATIVE COMPLICATIONS; SAN FRANCISCO; SOCIETIES, MEDICAL;

EID: 78651337155     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2010.12.005     Document Type: Article

References (168)

1. A. Cribier, H. Eltchaninoff, and A. Bash Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: first human case description Circulation 106 2002 3006 3008
2. A. Cribier, H. Eltchaninoff, and C. Tron Early experience with percutaneous transcatheter implantation of heart valve prosthesis for the treatment of end-stage inoperable patients with calcific aortic stenosis J Am Coll Cardiol 43 2004 698 703
3. B. Iung, G. Baron, and E.G. Butchart A prospective survey of patients with valvular heart disease in Europe: The Euro Heart Survey on Valvular Heart Disease Eur Heart J 24 2003 1231 1243
4. O. Stuge, and J. Liddicoat Emerging opportunities for cardiac surgeons within structural heart disease J Thorac Cardiovasc Surg 132 2006 1258 1261
5. P. Varadarajan, N. Kapoor, R.C. Bansal, and R.G. Pai Clinical profile and natural history of 453 nonsurgically managed patients with severe aortic stenosis Ann Thorac Surg 82 2006 2111 2115
6. K.A. Bramstedt Aortic valve replacement in the elderly: frequently indicated yet frequently denied Gerontology 49 2003 46 49
7. B. Iung, A. Cachier, and G. Baron Decision-making in elderly patients with severe aortic stenosis: why are so many denied surgery? Eur Heart J 26 2005 2714 2720
8. N. Piazza, O. Yoshinobu, P. de Jaegere, and P.W. Serruys Guidelines for reporting cardiac mortality and morbidity after cardiac valve interventionsneed for a reappraisal? Ann Thorac Surg 87 2009 357 358
9. C.W. Akins, E.H. Blackstone, C. Miller, N.T. Kouchoukos, and M.I. Turina Guidelines for reporting cardiac mortality and morbidity after cardiac valve interventionsneed for a reappraisal? Ann Thorac Surg 87 2009 359 360
10. M. Thomas, and O. Wendler Transcatheter aortic valve implantation (TAVI): how to interpret the data and what data is required? EuroIntervention 5 2008 25 27
11. N. Piazza, D.E. Cutlip, O. Yoshinobu, A.P. Kappetein, P. de Jaegere, and P.W. Serruys Clinical endpoints in transcatheter aortic valve implantation: a call to ARC for standardised definitons EuroIntervention 5 2008 28 29
12. C.W. Akins, D.C. Miller, and M.I. Turina Guidelines for reporting mortality and morbidity after cardiac valve interventions J Thorac Cardiovasc Surg 135 2008 732 738
13. K. Thygesen, J.S. Alpert, and H.D. White Universal definition of myocardial infarction J Am Coll Cardiol 50 2007 2173 2195 (Pubitemid 350123680)
14. D.E. Cutlip, S. Windecker, and R. Mehran Clinical end points in coronary stent trials: a case for standardized definitions Circulation 115 2007 2344 2351
15. F. Antonini-Canterin, E. Leiballi, and M. Capanna Association between carotid and coronary artery disease in patients with aortic valve stenosis: an angiographic study Angiology 60 2009 596 600
16. P. Kahlert, S.C. Knipp, and M. Schlamann Silent and apparent cerebral ischemia after percutaneous transfemoral aortic valve implantation: a diffusion-weighted magnetic resonance imaging study Circulation 121 2010 870 878
17. A. Ghanem, A. Muller, and C.P. Nahle Risk and fate of cerebral embolism after transfemoral aortic valve implantation: a prospective pilot study with diffusion-weighted magnetic resonance imaging J Am Coll Cardiol 55 2010 1427 1432
18. J.D. Easton, J.L. Saver, and G.W. Albers Definition and evaluation of transient ischemic attack: a scientific statement for healthcare professionals from the American Heart Association/American Stroke Association Stroke Council; Council on Cardiovascular Surgery and Anesthesia; Council on Cardiovascular Radiology and Intervention; Council on Cardiovascular Nursing; and the Interdisciplinary Council on Peripheral Vascular Disease Stroke 40 2009 2276 2293
19. J.L. Saver Proposal for a universal definition of cerebral infarction Stroke 39 2008 3110 3115
20. A.T. Ong, P.W. Serruys, and F.W. Mohr The SYNergy between percutaneous coronary intervention with TAXus and cardiac surgery (SYNTAX) study: design, rationale, and run-in phase Am Heart J 151 2006 1194 1204
21. M.E. Farkouh, G. Dangas, and M.B. Leon Design of the Future REvascularization Evaluation in patients with Diabetes mellitus: Optimal management of Multivessel disease (FREEDOM) trial Am Heart J 155 2008 215 223
22. H.S. Gurm, J.S. Yadav, and P. Fayad Long-term results of carotid stenting versus endarterectomy in high-risk patients N Engl J Med 358 2008 1572 1579
23. P.A. Ringleb, J. Allenberg, and H. Bruckmann 30 day results from the SPACE trial of stent-protected angioplasty versus carotid endarterectomy in symptomatic patients: a randomised non-inferiority trial Lancet 368 2006 1239 1247
24. R.W. Hobson II, V.J. Howard, and G.S. Roubin Carotid artery stenting is associated with increased complications in octogenarians: 30-day stroke and death rates in the CREST lead-in phase J Vasc Surg 40 2004 1106 1111
25. A.P. Maggioni, M.G. Franzosi, E. Santoro, H. White, F. Van de Werf, and G. Tognoni The risk of stroke in patients with acute myocardial infarction after thrombolytic and antithrombotic treatment Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico II (GISSI-2), and the International Study Group N Engl J Med 327 1992 1 6
26. ISIS-3 (Third International Study of Infarct Survival) Collaborative Group ISIS-3: a randomised comparison of streptokinase vs tissue plasminogen activator vs anistreplase and of aspirin plus heparin vs aspirin alone among 41,299 cases of suspected acute myocardial infarction Lancet 339 1992 753 770
27. J.M. Gore, C.B. Granger, and M.L. Simoons Stroke after thrombolysis Mortality and functional outcomes in the GUSTO-I trial. Global use of strategies to open occluded coronary arteries Circulation 92 1995 2811 2818
28. J.L. Halperin Ximelagatran compared with warfarin for prevention of thromboembolism in patients with nonvalvular atrial fibrillation: Rationale, objectives, and design of a pair of clinical studies and baseline patient characteristics (SPORTIF III and V) Am Heart J 146 2003 431 438
29. M.D. Ezekowitz, S. Connolly, and A. Parekh Rationale and design of RE-LY: randomized evaluation of long-term anticoagulant therapy, warfarin, compared with dabigatran Am Heart J 157 2009 805 810 e12
30. P. Totaro, D. Toni, and L. Durastanti Diffusion-weighted MRI in patients with non-diagnostic CT in the post-acute phase of cerebral ischemia Eur Neurol 63 2010 94 100
31. T. Brott, H.P. Adams Jr., and C.P. Olinger Measurements of acute cerebral infarction: a clinical examination scale Stroke 20 1989 864 870 (Pubitemid 19188240)
32. R. Bonita, and R. Beaglehole Modification of Rankin Scale: recovery of motor function after stroke Stroke 19 1988 1497 1500
33. L.B. Goldstein, and G.P. Samsa Reliability of the National Institutes of Health Stroke Scale Extension to non-neurologists in the context of a clinical trial Stroke 28 1997 307 310
34. P.D. Lyden, and G.T. Lau A critical appraisal of stroke evaluation and rating scales Stroke 22 1991 1345 1352
35. Standardized Definitions for Cardiovascular Outcomes Trials: FDA Draft Recommendations. Personal communication. March 24, 2010.
36. S.V. Manoukian, M.D. Voeltz, and J. Eikelboom Bleeding complications in acute coronary syndromes and percutaneous coronary intervention: predictors, prognostic significance, and paradigms for reducing risk Clin Cardiol 30 2007 II24 II34
37. F. Feit, M.D. Voeltz, and M.J. Attubato Predictors and impact of major hemorrhage on mortality following percutaneous coronary intervention from the REPLACE-2 trial Am J Cardiol 100 2007 1364 1369
38. G. Ndrepepa, P.B. Berger, and J. Mehilli Periprocedural bleeding and 1-year outcome after percutaneous coronary interventions: appropriateness of including bleeding as a component of a quadruple end point J Am Coll Cardiol 51 2008 690 697
39. A. Budaj, J.W. Eikelboom, and S.R. Mehta, OASIS 5 Investigators Improving clinical outcomes by reducing bleeding in patients with non-ST-elevation acute coronary syndromes Eur Heart J 30 2009 655 661
40. R. Mehran, S.J. Pocock, and G.W. Stone Associations of major bleeding and myocardial infarction with the incidence and timing of mortality in patients presenting with non-ST-elevation acute coronary syndromes: a risk model from the ACUITY trial Eur Heart J 30 2009 1457 1466
41. S.V. Rao, J.G. Jollis, and R.A. Harrington Relationship of blood transfusion and clinical outcomes in patients with acute coronary syndromes JAMA 292 2004 1555 1562
42. X. Yang, K.P. Alexander, and A.Y. Chen The implications of blood transfusions for patients with non-ST-segment elevation acute coronary syndromes: results from the CRUSADE National Quality Improvement Initiative J Am Coll Cardiol 46 2005 1490 1495
43. E. Nikolsky, R. Mehran, and H.M. Sadeghi Prognostic impact of blood transfusion after primary angioplasty for acute myocardial infarction: analysis from the CADILLAC (Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications) trial J Am Coll Cardiol Intv 2 2009 624 632
44. M.H. Shishehbor, S. Madhwal, and V. Rajagopal Impact of blood transfusion on short-and long-term mortality in patients with ST-segment elevation myocardial infarction J Am Coll Cardiol Intv 2 2009 46 53
45. The GUSTO Investigators An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction N Engl J Med 329 1993 673 682
46. Assessment of the Safety and Efficacy of a New Thrombolytic Regimen (ASSENT)-3 Investigators Efficacy and safety of tenecteplase in combination with enoxaparin, abciximab, or unfractionated heparin: the ASSENT-3 randomised trial in acute myocardial infarction Lancet 358 2001 605 613
47. H. White Thrombin-specific anticoagulation with bivalirudin versus heparin in patients receiving fibrinolytic therapy for acute myocardial infarction: the HERO-2 randomised trial Lancet 358 2001 1855 1863
48. R. Mehran, B. Brodie, and D.A. Cox The Harmonizing Outcomes with RevasculariZatiON and Stents in Acute Myocardial Infarction (HORIZONS-AMI) trial: study design and rationale Am Heart J 156 2008 44 56
49. E.M. Antman, C.H. McCabe, and E.P. Gurfinkel Enoxaparin prevents death and cardiac ischemic events in unstable angina/non-Q-wave myocardial infarction Results of the thrombolysis in myocardial infarction (TIMI) 11B trial Circulation 100 1999 1593 1601
50. M. Cohen, C. Demers, and E.P. Gurfinkel A comparison of low-molecular-weight heparin with unfractionated heparin for unstable coronary artery disease Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q-Wave Coronary Events Study Group N Engl J Med 337 1997 447 452
51. S.G. Goodman, D. Fitchett, P.W. Armstrong, M. Tan, and A. Langer Randomized evaluation of the safety and efficacy of enoxaparin versus unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndromes receiving the glycoprotein IIb/IIIa inhibitor eptifibatide Circulation 107 2003 238 244
52. M.A. Blazing, J.A. de Lemos, and H.D. White Safety and efficacy of enoxaparin vs unfractionated heparin in patients with non-ST-segment elevation acute coronary syndromes who receive tirofiban and aspirin: a randomized controlled trial JAMA 292 2004 55 64
53. SYNERGY Executive Committee The SYNERGY trial: study design and rationale Am Heart J 143 2002 952 960
54. S. Yusuf, S.R. Mehta, and S. Chrolavicius Comparison of fondaparinux and enoxaparin in acute coronary syndromes N Engl J Med 354 2006 1464 1476
55. A.M. Lincoff, N.S. Kleiman, and D.J. Kereiakes Long-term efficacy of bivalirudin and provisional glycoprotein IIb/IIIa blockade vs heparin and planned glycoprotein IIb/IIIa blockade during percutaneous coronary revascularization: REPLACE-2 randomized trial JAMA 292 2004 696 703
56. G.W. Stone, M. Bertrand, and A. Colombo Acute Catheterization and Urgent Intervention Triage strategY (ACUITY) trial: study design and rationale Am Heart J 148 2004 764 775
57. S. Subherwal, R.G. Bach, and A.Y. Chen Baseline risk of major bleeding in non-ST-segment-elevation myocardial infarction: the CRUSADE (Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the ACC/AHA Guidelines) bleeding score Circulation 119 2009 1873 1882
58. S.R. Mehta, J.P. Bassand, and S. Chrolavicius Design and rationale of CURRENT-OASIS 7: a randomized, 2 × 2 factorial trial evaluating optimal dosing strategies for clopidogrel and aspirin in patients with ST and non-ST-elevation acute coronary syndromes managed with an early invasive strategy Am Heart J 156 2008 1080 1088 e1
59. S. James, A. Akerblom, and C.P. Cannon Comparison of ticagrelor, the first reversible oral P2Y(12) receptor antagonist, with clopidogrel in patients with acute coronary syndromes: rationale, design, and baseline characteristics of the PLATelet inhibition and patient Outcomes (PLATO) trial Am Heart J 157 2009 599 605
60. S. Schulman, and C. Kearon Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients J Thromb Haemost 3 2005 692 694
61. E.M. Levy, C.M. Viscoli, and R.I. Horwitz The effect of acute renal failure on mortality A cohort analysis JAMA 275 1996 1489 1494
62. P.A. McCullough, R. Wolyn, L.L. Rocher, R.N. Levin, and W.W. O'Neill Acute renal failure after coronary intervention: incidence, risk factors, and relationship to mortality Am J Med 103 1997 368 375
63. C.M. Mangano, L.S. Diamondstone, J.G. Ramsay, A. Aggarwal, A. Herskowitz, and D.T. Mangano Renal dysfunction after myocardial revascularization: risk factors, adverse outcomes, and hospital resource utilization The Multicenter Study of Perioperative Ischemia Research Group Ann Intern Med 128 1998 194 203
64. L. Gruberg, G.S. Mintz, and R. Mehran The prognostic implications of further renal function deterioration within 48 h of interventional coronary procedures in patients with pre-existent chronic renal insufficiency J Am Coll Cardiol 36 2000 1542 1548
65. P.J. Best, R. Lennon, and H.H. Ting The impact of renal insufficiency on clinical outcomes in patients undergoing percutaneous coronary interventions J Am Coll Cardiol 39 2002 1113 1119
66. K. Nash, A. Hafeez, and S. Hou Hospital-acquired renal insufficiency Am J Kidney Dis 39 2002 930 936
67. C.S. Rihal, S.C. Textor, and D.E. Grill Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention Circulation 105 2002 2259 2264
68. P.E. Antunes, D. Prieto, J. Ferrao de Oliveira, and M.J. Antunes Renal dysfunction after myocardial revascularization Eur J Cardiothorac Surg 25 2004 597 604
69. A. Lassnigg, D. Schmidlin, and M. Mouhieddine Minimal changes of serum creatinine predict prognosis in patients after cardiothoracic surgery: a prospective cohort study J Am Soc Nephrol 15 2004 1597 1605
70. G.M. Chertow, E. Burdick, M. Honour, J.V. Bonventre, and D.W. Bates Acute kidney injury, mortality, length of stay, and costs in hospitalized patients J Am Soc Nephrol 16 2005 3365 3370
71. F. Aregger, P. Wenaweser, and G.J. Hellige Risk of acute kidney injury in patients with severe aortic valve stenosis undergoing transcatheter valve replacement Nephrol Dial Transplant 24 2009 2175 2179
72. R. Bagur, J.G. Webb, and F. Nietlispach J. Acute kidney injury following transcatheter aortic valve implantation: predictive factors, prognostic value, and comparison with surgical aortic valve replacement Eur Heart J 31 2010 865 874
73. N. Lameire, W. Van Biesen, and R. Vanholder The changing epidemiology of acute renal failure Nat Clin Pract Nephrol 2 2006 364 377
74. R. Bellomo, C. Ronco, J.A. Kellum, R.L. Mehta, and P. Palevsky Acute renal failure definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group Crit Care 8 2004 R204 R212
75. R. Bellomo, J.A. Kellum, and C. Ronco Defining acute renal failure: physiological principles Intensive Care Med 30 2004 33 37 (Pubitemid 38147105)
76. J.A. Kellum, N. Levin, C. Bouman, and N. Lameire Developing a consensus classification system for acute renal failure Curr Opin Crit Care 8 2002 509 514
77. N.Y. Abosaif, Y.A. Tolba, M. Heap, J. Russell, and A.M. El Nahas The outcome of acute renal failure in the intensive care unit according to RIFLE: model application, sensitivity, and predictability Am J Kidney Dis 46 2005 1038 1048
78. M. Bell, E. Liljestam, F. Granath, J. Fryckstedt, A. Ekbom, and C.R. Martling Optimal follow-up time after continuous renal replacement therapy in actual renal failure patients stratified with the RIFLE criteria Nephrol Dial Transplant 20 2005 354 360
79. E.A. Hoste, G. Clermont, and A. Kersten RIFLE criteria for acute kidney injury are associated with hospital mortality in critically ill patients: a cohort analysis Crit Care 10 2006 R73
80. A. Kuitunen, A. Vento, R. Suojaranta-Ylinen, and V. Pettila Acute renal failure after cardiac surgery: evaluation of the RIFLE classification Ann Thorac Surg 81 2006 542 546
81. S. Uchino, R. Bellomo, D. Goldsmith, S. Bates, and C. Ronco An assessment of the RIFLE criteria for acute renal failure in hospitalized patients Crit Care Med 34 2006 1913 1917 (Pubitemid 43982467)
82. R.L. Mehta, J.A. Kellum, and S.V. Shah Acute kidney injury network: report of an initiative to improve outcomes in acute kidney injury Crit Care 11 2007 R31
83. N.V. Guitterez, A. Diaz, and G.C. Timmis Determinants of serum creatinine trajectory in acute contrast nephropathy J Interv Cardiol 15 2002 349 354
84. N.M. Van Mieghem, R.J. Nuis, and N. Piazza Vascular complications with transcatheter aortic valve implantation using the 18 Fr Medtronic CoreValve System(R): the Rotterdam experience EuroIntervention 5 2010 673 679
85. G. Ducrocq, F. Francis, and J.M. Serfaty Vascular complications of transfemoral aortic valve implantation with the Edwards SAPIEN prosthesis: incidence and impact on outcome EuroIntervention 5 2010 666 672
86. D. Tchetche, N. Dumonteil, and A. Sauguet Thirty-day outcome and vascular complications after transarterial aortic valve implantation using both Edwards Sapien and Medtronic CoreValve(R) bioprostheses in a mixed population EuroIntervention 5 2010 659 665
87. P. Kahlert, F. Al-Rashid, and M. Weber Vascular access site complications after percutaneous transfemoral aortic valve implantation Herz 34 2009 398 408
88. E.L. Chaikof, J.D. Blankensteijn, and P.L. Harris Reporting standards for endovascular aortic aneurysm repair J Vasc Surg 35 2002 1048 1060
89. S. Bleiziffer, H. Ruge, and D. Mazzitelli Survival after transapical and transfemoral aortic valve implantation: talking about two different patient populations J Thorac Cardiovasc Surg 138 2009 1073 1080
90. W.A. Zoghbi, J.B. Chambers, and J.G. Dumesnil Recommendations for evaluation of prosthetic valves with echocardiography and doppler ultrasound: a report From the American Society of Echocardiography's Guidelines and Standards Committee and the Task Force on Prosthetic Valves, developed in conjunction with the American College of Cardiology Cardiovascular Imaging Committee, Cardiac Imaging Committee of the American Heart Association, the European Association of Echocardiography, a registered branch of the European Society of Cardiology, the Japanese Society of Echocardiography and the Canadian Society of Echocardiography, endorsed by the American College of Cardiology Foundation, American Heart Association, European Association of Echocardiography, a registered branch of the European Society of Cardiology, the Japanese Society of Echocardiography, and Canadian Society of Echocardiography J Am Soc Echocardiogr 22 2009 975 1014 quiz 10824
91. A. Vahanian, H. Baumgartner, and J. Bax Guidelines on the management of valvular heart disease: The Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology Eur Heart J 28 2007 230 268
92. R.O. Bonow, B.A. Carabello, and K. Chatterjee Focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons Circulation 118 2008 e523 e661
93. C.J. Schultz, A. Weustink, and N. Piazza Geometry and degree of apposition of the CoreValve ReValving system with multislice computed tomography after implantation in patients with aortic stenosis J Am Coll Cardiol 54 2009 911 918
94. C. Schultz, N. Piazza, R.J. van Geuns, P. de Feyter, P. Serruys, and P. de Jaegere Tips and Tricks for Imaging Percutaneously Implanted Aortic Valve Prostheses 2010 Informa Healthcare New York, NY 275 287
95. A. Cribier, H. Eltchaninoff, and C. Tron Treatment of calcific aortic stenosis with the percutaneous heart valve: mid-term follow-up from the initial feasibility studies: the French experience J Am Coll Cardiol 47 2006 1214 1223
96. J.G. Webb, L. Altwegg, and R.H. Boone Transcatheter aortic valve implantation: impact on clinical and valve-related outcomes Circulation 119 2009 3009 3016
97. L.B. Eberhard Grube, M. Ralf, and S. Barthel Progress and current status of percutaneous aortic valve replacement: results of three device generations of the corevalve revalving system Circ Cardiovasc Intervent 1 2008 167 175
98. N. Piazza, E. Grube, and U. Gerckens Procedural and 30-day outcomes following transcatheter aortic valve implantation using the third generation (18 Fr) corevalve revalving system: results from the multicentre, expanded evaluation registry 1-year following CE mark approval EuroIntervention 4 2008 242 249
99. T. Walther, P. Simon, and T. Dewey Transapical minimally invasive aortic valve implantation: multicenter experience Circulation 116 2007 1240 1245
100. L.G. Svensson, T. Dewey, and S. Kapadia United States feasibility study of transcatheter insertion of a stented aortic valve by the left ventricular apex Ann Thorac Surg 86 2008 46 54
101. D. Himbert, F. Descoutures, and N. Al-Attar Results of transfemoral or transapical aortic valve implantation following a uniform assessment in high-risk patients with aortic stenosis J Am Coll Cardiol 54 2009 303 311
102. P. De Jaegere, N. Piazza, and T. Galema Early echocardiographic evaluation following percutaneous implantation with the self-expanding CoreValve ReValving System aortic valve bioprosthesis Eurointervention 4 2008 351 357
103. D. Detaint, L. Lepage, and D. Himbert Determinants of significant paravalvular regurgitation after transcatheter aortic valve: implantation impact of device and annulus discongruence J Am Coll Cardiol Intv 2 2009 821 827
104. M.A. Clavel, J.G. Webb, and P. Pibarot Comparison of the hemodynamic performance of percutaneous and surgical bioprostheses for the treatment of severe aortic stenosis J Am Coll Cardiol 53 2009 1883 1891
105. V.G. Davila-Roman, A.D. Waggoner, and E.D. Kennard Prevalence and severity of paravalvular regurgitation in the Artificial Valve Endocarditis Reduction Trial (AVERT) echocardiography study J Am Coll Cardiol 44 2004 1467 1472
106. A. Ionescu, A.G. Fraser, and E.G. Butchart Prevalence and clinical significance of incidental paraprosthetic valvar regurgitation: a prospective study using transoesophageal echocardiography Heart 89 2003 1316 1321
107. D.J. O'Rourke, R.T. Palac, D.J. Malenka, C.A. Marrin, B.E. Arbuckle, and J.F. Plehn Outcome of mild periprosthetic regurgitation detected by intraoperative transesophageal echocardiography J Am Coll Cardiol 38 2001 163 166
108. L.S. Rallidis, I.E. Moyssakis, I. Ikonomidis, and P. Nihoyannopoulos Natural history of early aortic paraprosthetic regurgitation: a five-year follow-up Am Heart J 138 1999 351 357
109. I.I. Kupferwasser, S. Mohr-Kahaly, and R. Erbel Improved assessment of pathological regurgitation in patients with prosthetic heart valves by multiplane transesophageal echocardiography Echocardiography 14 1997 363 374
110. S. Mohr-Kahaly, I. Kupferwasser, R. Erbel, H. Oelert, and J. Meyer Regurgitant flow in apparently normal valve prostheses: improved detection and semiquantitative analysis by trans-esophageal two-dimensional color-coded Doppler echocardiography J Am Soc Echocardiogr 3 1990 187 195
111. S. Mohr-Kahaly, I. Kupferwasser, and R. Erbel Value and limitations of transesophageal echocardiography in the evaluation of aortic prostheses J Am Soc Echocardiogr 6 1993 12 20
112. T. Trepels, S. Martens, M. Doss, S. Fichtlscherer, and V. Schachinger Images in cardiovascular medicine Thrombotic restenosis after minimally invasive implantation of aortic valve stent Circulation 120 2009 e23 e24
113. D.T. Durack, A.S. Lukes, and D.K. Bright New criteria for diagnosis of infective endocarditis: utilization of specific echocardiographic findings Duke Endocarditis Service Am J Med 96 1994 200 209
114. C. Comoglio, M. Boffini, and S. El Qarra Aortic valve replacement and mitral valve repair as treatment of complications after percutaneous core valve implantation J Thorac Cardiovasc Surg 138 2009 1025 1027
115. D.R. Wong, R.H. Boone, and C.R. Thompson Mitral valve injury late after transcatheter aortic valve implantation J Thorac Cardiovasc Surg 137 2009 1547 1549 e
116. N. Piazza, S. Marra, and J. Webb Two cases of Aneurysm of the Anterior Mitral Valve Leaflet associated with Transcatheter Aortic Valve Endocarditis (TAVE): a mere coincidence? J Cardiothorac Surg 140 2010 e36 e38
117. N. Piazza, P. de Jaegere, C. Schultz, A.E. Becker, P.W. Serruys, and R.H. Anderson Anatomy of the aortic valvar complex and its implications for transcatheter implantation of the aortic valve Circ Cardiovasc Intervent 1 2008 74 81
118. R. Moreno, D. Dobarro, E. Lopez de Sa, and M. Prieto Cause of complete atrioventricular block after percutaneous aortic valve implantation: insights from a necropsy study Circulation 120 2009 e29 e30
119. Z.T.B. El-Khally, C. Staniloae, and P. Theroux Prognostic significance of newly acquired bundle branch block after aortic valve replacement Am J Cardiol 94 2004 1008 1011
120. J.L. Thomas, R.A. Dickstein, and F.B. Parker Jr. Prognostic significance of the development of left bundle conduction defects following aortic valve replacement J Thorac Cardiovasc Surg 84 1982 382 386
121. G. Limongelli, V. Ducceschi, and A. D'Andrea Risk factors for pacemaker implantation following aortic valve replacement: a single centre experience Heart 89 2003 901 904
122. R.S. Gordon, J. Ivanov, G. Cohen, and A.L. Ralph-Edwards Permanent cardiac pacing after a cardiac operation: predicting the use of permanent pacemakers Ann Thorac Surg 66 1998 1698 1704
123. S. Dawkins, A.R. Hobson, P.R. Kalra, A.T. Tang, J.L. Monro, and K.D. Dawkins Permanent pacemaker implantation after isolated aortic valve replacement: incidence, indications, and predictors Ann Thorac Surg 85 2008 108 112
124. A. Sinhal, L. Altwegg, and S. Pasupati Atrioventricular block after transcatheter balloon expandable aortic valve implantation J Am Coll Cardiol Intv 1 2008 305 309
125. H. Jilaihawi, D. Chin, and M. Vasa-Nicotera Predictors for permanent pacemaker requirement after transcatheter aortic valve implantation with the CoreValve bioprosthesis Am Heart J 157 2009 860 866
126. V. Calvi, E. Puzzangara, and G.P. Pruiti Early conduction disorders following percutaneous aortic valve replacement Pacing Clin Electrophysiol 32 Suppl 1 2009 S126 S130
127. M. Gutierrez, J. Rodes-Cabau, and R. Bagur Electrocardiographic changes and clinical outcomes after transapical aortic valve implantation Am Heart J 158 2009 302 308
128. N. Piazza, Y. Onuma, and E. Jesserun Early and persistent intraventricular conduction abnormalities and requirements for pacemaking after percutaneous replacement of the aortic valve J Am Coll Cardiol Intv 1 2008 310 316
129. E. Orlowska-Baranowska, R. Baranowski, P. Michalek, P. Hoffman, T. Rywik, and I. Rawczylska-Englert Prediction of paroxysmal atrial fibrillation after aortic valve replacement in patients with aortic stenosis: identification of potential risk factors J Heart Valve Dis 12 2003 136 141
130. M. Banach, A. Goch, M. Misztal, J. Rysz, R. Jaszewski, and J.H. Goch Predictors of paroxysmal atrial fibrillation in patients undergoing aortic valve replacement J Thorac Cardiovasc Surg 134 2007 1569 1576
131. J.G. Webb, S. Pasupati, and K. Humphries Percutaneous transarterial aortic valve replacement in selected high-risk patients with aortic stenosis Circulation 116 2007 755 763
132. J.G. Webb Coronary obstruction due to transcatheter valve implantation Catheter Cardiovasc Interv 73 2009 973
133. N. Al-Attar, W. Ghodbane, and D. Himbert Unexpected complications of transapical aortic valve implantation Ann Thorac Surg 88 2009 90 94
134. A. Tzikas, C. Schultz, N. Piazza, R.J. van Geuns, P.W. Serruys, and P.P. de Jaegere Perforation of the membranous interventricular septum after transcatheter aortic valve implantation Circ Cardiovasc Interv 2 2009 582 583
135. S.A. Hunt, W.T. Abraham, and M.H. Chin Focused update incorporated into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the International Society for Heart and Lung Transplantation Circulation 119 2009 e391 e479
136. G.H. Guyatt, M.J. Sullivan, and P.J. Thompson The 6-minute walk: a new measure of exercise capacity in patients with chronic heart failure Can Med Assoc J 132 1985 919 923
137. The Criteria Committee of the New York Heart Association B. Little, Diseases of the heart and blood vessels: nomenclature and criteria for diagnosis 6th edition 1964 Little, Brown Boston, MA
138. Group TE EuroQola new facility for the measurement of health-related quality of life The EuroQol Group Health Policy 16 1990 199 208
139. L.P. Fried, C.M. Tangen, and J. Walston Frailty in older adults: evidence for a phenotype J Gerontol A Biol Sci Med Sci 56 2001 M146 M156
140. C.P. Green, C.B. Porter, D.R. Bresnahan, and J.A. Spertus Development and evaluation of the Kansas City Cardiomyopathy Questionnaire: a new health status measure for heart failure J Am Coll Cardiol 35 2000 1245 1255
141. R. Brooks, R. Rabin, F. de Charro, The Measurement and Valuation of Health Status Using EQ-5D: A European Perspective: Evidence from the EuroQol BIO MED Research Programme 2003 Kluwer Academic Publishers Rotterdam
142. J. Spertus, E. Peterson, and M.W. Conard Monitoring clinical changes in patients with heart failure: a comparison of methods Am Heart J 150 2005 707 715
143. G.P. Ussia, M. Mule, and M. Barbanti Quality of life assessment after percutaneous aortic valve implantation Eur Heart J 30 2009 1790 1796
144. C.H. Winograd, M.B. Gerety, M. Chung, M.K. Goldstein, F. Dominguez Jr., and R. Vallone Screening for frailty: criteria and predictors of outcomes J Am Geriatr Soc 39 1991 778 784
145. D. Hamerman Toward an understanding of frailty Ann Intern Med 130 1999 945 950
146. D.H. Lee, K.J. Buth, and B.J. Martin Frail patients are at increased risk for mortality and prolonged institutional care after cardiac surgery Circulation 121 2010 973 978
147. Disability and frailty among elderly Canadians: a comparison of six surveys Int Psychogeriatr 13 Supp 1 2001 159 167
148. A.P.M.J. Chin, L.C. de Groot, and S.V. van Gend Inactivity and weight loss: effective criteria to identify frailty J Nutr Health Aging 7 2003 55 60
149. T. Walther, V. Falk, and J. Kempfert Transapical minimally invasive aortic valve implantation; the initial 50 patients Eur J Cardiothorac Surg 33 2008 983 988
150. J.G. Webb, M. Chandavimol, and C.R. Thompson Percutaneous aortic valve implantation retrograde from the femoral artery Circulation 113 2006 842 850
151. E. Ferrari, E. Rizzo, C. Sulzer, and L.K. von Segesser Unexpected left ventricular free-wall rupture following an aortic catheter-valve implantation Eur J Cardiothorac Surg 37 2010 242 244
152. L.C. Maroto, J.E. Rodriguez, J. Cobiella, and J. Silva Delayed dislocation of a transapically implanted aortic bioprosthesis Eur J Cardiothorac Surg 36 2009 935 937
153. M.A. Clavel, E. Dumont, and P. Pibarot Severe valvular regurgitation and late prosthesis embolization after percutaneous aortic valve implantation Ann Thorac Surg 87 2009 621 623
154. C. Ruiz, J. Laborde, J. Condado, P. Chiam, and J. Condado First percutaneous transcatheter aortic valve-in-valve implant with three year follow-up Catheter Cardiovasc Interv 72 2008 143 148
155. N. Piazza, C. Schultz, P.P. de Jaegere, and P.W. Serruys Implantation of two self-expanding aortic bioprosthetic valves during the same procedure-Insights into valve-in-valve implantation ('Russian doll concept') Catheter Cardiovasc Interv 73 2009 530 539
156. P. Montorsi, F. De Bernardi, M. Muratori, D. Cavoretto, and M. Pepi Role of cine-fluoroscopy, transthoracic, and transesophageal echocardiography in patients with suspected prosthetic heart valve thrombosis Am J Cardiol 85 2000 58 64
157. T.E. Cianciulli, J.A. Lax, and M.A. Beck Cinefluoroscopic assessment of mechanical disc prostheses: its value as a complementary method to echocardiography J Heart Valve Dis 14 2005 664 673
158. N. Piazza, E. Grube, and U. Gerckens A clinical protocol for analysis of the structural integrity of the Medtronic CoreValve System(R) frame and its application in patients with 1-year minimum follow-up EuroIntervention 5 2010 680 686
159. H.G. Thyregod, J.T. Lund, T. Engstrøm, and D.A. Steinbruchel Transcatheter aortic valve prosthesis surgically replaced 4 months after implantation Eur J Cardiothorac Surg 37 2010 494 496
160. T.K. Rosengart, T. Feldman, M.A. Borger American Heart Association Council on Cardiovascular Surgery and Anesthesia; American Heart Association Council on Clinical Cardiology; Functional Genomics and Translational Biology Interdisciplinary Working Group; Quality of Care and Outcomes Research Interdisciplinary Working Group Percutaneous and minimally invasive valve procedures: a scientific statement from the American Heart Association Council on Cardiovascular Surgery and Anesthesia, Council on Clinical Cardiology, Functional Genomics and Translational Biology Interdisciplinary Working Group, and Quality of Care and Outcomes Research Interdisciplinary Working Group Circulation 117 2008 1750 1767
161. A. Vahanian, O. Alfieri, N. Al-Attar European Association of Cardio-Thoracic Surgery; European Society of Cardiology; European Association of Percutaneous Cardiovascular Interventions Transcatheter valve implantation for patients with aortic stenosis: a position statement from the European Association of Cardio-Thoracic Surgery (EACTS) and the European Society of Cardiology (ESC), in collaboration with the European Association of Percutaneous Cardiovascular Interventions (EAPCI) Eur Heart J 29 2008 1463 1470
162. L. Buellesfeld, U. Gerckens, and E. Grube Percutaneous implantation of the first repositionable aortic valve prosthesis in a patient with severe aortic stenosis Catheter Cardiovasc Interv 71 2008 579 584
163. J. Schofer, M. Schluter, and H. Treede Retrograde transarterial implantation of a nonmetallic aortic valve prosthesis in high-surgical-risk patients with severe aortic stenosis: a first-in-man feasibility and safety study Circ Cardiovasc Interv 1 2008 126 133
164. F. Nietlispach, N. Wijesinghe, D. Wood, R.G. Carere, and J.G. Webb Current balloon-expandable transcatheter heart valve and delivery systems Catheter Cardiovasc Interv 75 2010 295 300
165. V. Falk, E.E. Schwammenthal, and J. Kempfert New anatomically oriented transapical aortic valve implantation Ann Thorac Surg 87 2009 925 926
166. T. Feldman, H.S. Wasserman, and H.C. Herrmann Percutaneous mitral valve repairusing the edge-to-edge technique: six-month results of the EVEREST Phase 1 Clinical trial J Am Coll Cardiol 46 2005 2134 2140
167. T. Feldman, S. Kar, M. Rinaldi EVEREST Investigators Percutaneous mitral repair with the MitraClip system: safety and mid-term durability in the initial EVEREST (Endovascular Valve Edge-to-Edge REpair Study) cohort J Am Coll Cardiol 54 2009 686 694
168. Feldman T, Mauri L, Foster E, Glower D, on behalf of the EVEREST II Investigators. Endovascular valve edge-to-edge repair study (EVEREST II) randomized clinical trial: primary safety and efficacy endpoints. Presented at: ACC late breaking clinical trial, March 14, 2010.